Larimar Therapeutics
top line phase cohort data initiation in | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
18 of 44
Related slides by other companies
Adagio Therapeutics
Investor Presentation
May 2023
ongoing phase trial of with initial data planned for | Adagio Therapeutics
Ocuphire Pharma
Investor Presentation
November 2021
overview | Ocuphire Pharma
Exscientia
Results
August 2023
elucidate phase ongoing in advanced solid identified to be further assessed in the trial | Exscientia
BioNTech
Results
August 2020
rationale for selection of for pivotal phase trial | BioNTech
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Results
November 2022
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights